How combination therapies lead to better treatment results

Inflammatory bowel diseases (IBD) are complex and multifactorial diseases that require a differentiated and evolving treatment approach. When monotherapies reach their limits, the need for combination strategies grows. The focus is on both conventional combination regimens and innovative applications of dual biological (targeted) therapies.